Heterocyclic urea derivatives and methods of use thereof (WO2010142978).

Authors:
Address: Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Via della Lastruccia 3, I-50019 Sesto Fiorentino (Firenze), Italy.
Journal:


Publication:

abstract

A series of ureido derivatives incorporating a highly derivatized quinolone scaffold were prepared by a succession of original steps. The lead molecules of these compounds are the quinolone antibacterials of the nalidixic acid/ciprofloxacin type and they target, similar to these clinically used agents, the DNA gyrase/topoisomerase IV of pathogenic bacteria. These new quinolones are claimed to act as efficient antibacterials against a large number of drug-resistant bacteria such as Staphylococcus spp., Enterococcus spp., Streptococcus spp., Acinetobacter baumannii, Bacteroides bivius, Burkholderia spp., Chlamydia spp., Chlamydophila pneumoniae.



Related Articles
[The history of the development and changes of quinolone antibacterial agents].
Yakushigaku Zasshi. 2003
[The history of the development and changes of quinolone antibacterial agents].
Takahashi H, Hayakawa I, Akimoto T. Yakushigaku Zasshi. 2003; 38(2):161-79.
Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2...
Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.
Gould KA, Pan XS, Kerns RJ, Fisher LM. Antimicrob Agents Chemother. 2004 Jun; 48(6):2108-15.
Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
Antimicrob Agents Chemother. 2...
Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
Yague G, Morris JE, Pan XS, Gould KA, Fisher LM. Antimicrob Agents Chemother. 2002 Feb; 46(2):413-9.
Review Quinolone mode of action.
Drugs. 1995
Review Quinolone mode of action.
Hooper DC. Drugs. 1995; 49 Suppl 2:10-5.
Review Non-fluorinated quinolones (NFQs): new antibacterials with unique properties against quinolone-resistant gram-positive pathogens.
Curr Drug Targets Infect Disor...
Review Non-fluorinated quinolones (NFQs): new antibacterials with unique properties against quinolone-resistant gram-positive pathogens.
Roychoudhury S, Ledoussal B. Curr Drug Targets Infect Disord. 2002 Mar; 2(1):51-65.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.